Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

Biochemical Journal

Volumn 441, Issue 1, 2012, Pages 1-21

  Magnuson, Brian ^a   Ekim, Bilgen ^a   Fingar, Diane C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Mammalian target of rapamycin complex 1 (mTORC1); Mammalian target of rapamycin complex 2 (mTORC2); S6 kinase 1 (S6K1); S6 kinase 2 (S6K2); Target of rapamycin (TOR)

Indexed keywords

I KAPPA B KINASE BETA; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOLIPASE D; RAPAMYCIN; RAS PROTEIN; S6 KINASE; TUMOR NECROSIS FACTOR ALPHA;

ACETYLATION; AGING; ALLELE; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; BODY MASS; CANCER CHEMOTHERAPY; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; CELLULAR DISTRIBUTION; DIABETES MELLITUS; ENERGY; ENERGY BALANCE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEEDBACK SYSTEM; GENE EXPRESSION; GENE MUTATION; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTROPHY; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INSULIN SENSITIVITY; LEARNING; LYMPHOCYTE PROLIFERATION; MEMORY; NEOPLASM; NONHUMAN; OBESITY; ORGAN GROWTH; ORGAN SIZE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION; TERMINAL OLIGOPYRIMIDINE TRACT; UBIQUITINATION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84055178474     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110892     Document Type: Review

References (233)

1. Foster, K. G. and Fingar, D. C. (2010) Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J. Biol. Chem. 285, 14071-14077
2. Zoncu, R., Efeyan, A. and Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35
3. Alessi, D. R., Pearce, L. R. and Garcia-Martinez, J. M. (2009) New insights into mTOR signaling: mTORC2 and beyond. Sci. Signaling 2, pe27
4. Augustine, J. J., Bodziak, K. A. and Hricik, D. E. (2007) Use of sirolimus in solid organ transplantation. Drugs 67, 369-391 (Pubitemid 46425551)
5. Wessely, R. (2010) New drug-eluting stent concepts. Nat. Rev. Cardiol. 7, 194-203
6. Guertin, D. A. and Sabatini, D. M. (2009) The pharmacology of mTOR inhibition. Sci. Signaling 2, pe24
7. Liu, Q., Thoreen, C., Wang, J., Sabatini, D. and Gray, N. S. (2009) mTOR mediated anti-cancer drug discovery. Drug Discovery Today Ther. Strateg. 6, 47-55
8. Fenton, T. R. and Gout, I. T. (2011) Functions and regulation of the 70kDa ribosomal S6 kinases. Int. J. Biochem. Cell Biol. 43, 47-59
9. Meyuhas, O. and Dreazen, A. (2009) Ribosomal protein S6 kinase from TOP mRNAs to cell size. Prog. Mol. Biol. Transl. Sci. 90, 109-153
10. Ma, X. M. and Blenis, J. (2009) Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307-318
11. Meyuhas, O. (2008) Physiological roles of ribosomal protein S6: one of its kind. Int. Rev. Cell Mol. Biol. 268, 1-37
12. Banerjee, P., Ahmad, M. F., Grove, J. R., Kozlosky, C., Price, D. J. and Avruch, J. (1990) Molecular structure of a major insulin/mitogen-activated 70-kDa S6 protein kinase. Proc. Natl. Acad. Sci. U.S.A. 87, 8550-8554
13. Kozma, S. C., Ferrari, S., Bassand, P., Siegmann, M., Totty, N. and Thomas, G. (1990) Cloning of the mitogen-activated S6 kinase from the rat liver reveals an enzyme of the second messenger subfamily. Proc. Natl. Acad. Sci. U.S.A. 87, 7365-7369
14. s6k gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17, 6649-6659
15. Lee-Fruman, K. K., Kuo, C. J., Lippincott, J., Terada, N. and Blenis, J. (1999) Characterization of S6K2, a novel kinase homologous to S6K1. Oncogene 18, 5108-5114 (Pubitemid 29443756)
16. Gout, Y., Minami, T., Hara, K., Tsujishita, Y., Filonenko, V., Waterfirld, M. D. and Yonezawa, K. (1998) Molecular cloning and characterization of a novel S6 kinase, p70 S6 kinase β containing a proline-rich region. J. Biol. Chem. 273, 30061-30064 (Pubitemid 28545462)
17. Koh, H., Jee, K., Lee, B., Kim, J., Kim, D., Yun, Y. H., Kim, J. W., Choi, H.-S. and Chung, J. (1999) Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); A novel nuclear target of Akt. Oncogene 18, 5115-5119 (Pubitemid 29443757)
18. Saitoh, M., ten Dijke, P., Miyazono, K. and Ichijo, H. (1998) Cloning and characterization of p70(S6Kβ) defines a novel family of p70 S6 kinases. Biochem. Biophys. Res. Commun. 253, 470-476 (Pubitemid 29026726)
19. -/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveals a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell. Biol. 24, 3112-3124
20. Gangloff, Y. G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J. F., Um, S. H., Brown, E. J., Cereghini, S., Thomas, G. and Kozma, S. C. (2004) Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol. Cell. Biol. 24, 9508-9516 (Pubitemid 39391687)
21. Murakami, M., Ichisaka, T., Maeda, M., Oshiro, N., Hara, K., Edenhofer, F., Kiyama, H., Yonezawa, K. and Yamanaka, S. (2004) mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol. Cell. Biol. 24, 6710-6718 (Pubitemid 38944350)
22. Dann, S. G., Selvaraj, A. and Thomas, G. (2007) mTOR complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol. Med. 13, 252-259 (Pubitemid 46836871)
23. Sehgal, S. N., Baker, H. and Vezina, C. (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J. Antibiot. 28, 727-732
24. Diamond, J. (2005) Collapse: How Societies Choose To Fail Or Succeed, pp. 79-119, Viking Penguin, New York
25. Abraham, R. T. and Wiederrecht, G. J. (1996) Immunopharmacology of rapamycin. Annu. Rev. Immunol. 14, 483-510 (Pubitemid 26130192)
26. Martel, R. R., Klicius, J. and Galet, S. (1977) Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can. J. Physiol. Pharmacol. 55, 48-51 (Pubitemid 8061941)
27. Heitman, J., Movva, N. R. and Hall, M. N. (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905-909 (Pubitemid 21917235)
28. Jones, S. W., Erikson, E., Blenis, J., Maller, J. L. and Erikson, R. L. (1988) A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases. Proc. Natl. Acad. Sci. U.S.A. 85, 3377-3381
29. Carriere, A., Ray, H., Blenis, J. and Roux, P. P. (2008) The RSK factors of activating the Ras/MAPK signaling cascade. Front. Biosci. 13, 4258-4275 (Pubitemid 351611599)
30. Chung, J., Kuo, C. J., Crabtree, G. R. and Blenis, J. (1992) Rapamycin-FKBP specifically blocks growth-dependent activation of and signalling by the 70kD S6 protein kinases. Cell 69, 1227-1236
31. Kuo, C. J., Chung, J., Florentino, D. F., Flanagan, W. M., Blenis, J. and Crabtree, G. R. (1992) Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358, 70-73
32. Price, D. J., Grove, J. R., Calvo, V., Avruch, J. and Bierer, B. E. (1992) Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257, 973-977
33. Pearson, R. B., Dennis, P. B., Han, J. W., Williamson, N. A., Kozma, S. C., Wettenhall, R. E. and Thomas, G. (1995) The principal target of rapamycin-induced p70S6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14, 5279-5287
34. Beretta, L., Gingras, A. C., Svitkin, Y. V., Hall, M. N. and Sonenberg, N. (1996) Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap- dependent initiation of translation. EMBO J. 15, 658-664 (Pubitemid 26044579)
35. Brunn, G. J., Hudson, C. C., Sekulic, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, Jr, J. C. and Abraham, R. T. (1997) Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277, 99-101 (Pubitemid 27450655)
36. Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H. and Sabatini, D. M. (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. U.S.A. 95, 1432-1437 (Pubitemid 28103409)
37. Isotani, S., Hara, K., Tokunaga, C., Inoue, H., Avruch, J. and Yonezawa, K. (1999) Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase α in vitro. J. Biol. Chem. 274, 34493-34498 (Pubitemid 129511797)
38. Alessi, D. R., Kozlowski, M. T., Weng, Q. P., Morrice, N. and Avruch, J. (1998) 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8, 69-81 (Pubitemid 28104519)
39. Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma, S. C., Hemmings, B. A. and Thomas, G. (1998) Phosphorylation and activation of p70s6k by PDK1. Science 279, 707-710
40. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J. and Yonezawa, K. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189 (Pubitemid 34876546)
41. Kim, D. H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D. M. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (Pubitemid 34876545)
42. Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P. and Hall, M. N. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457-468 (Pubitemid 35284167)
43. Jacinto, E. and Lorberg, A. (2008) TOR regulation of AGC kinases in yeast and mammals. Biochem. J. 410, 19-37 (Pubitemid 351300322)
44. Pearce, L. R., Komander, D. and Alessi, D. R. (2010) The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11, 9-22
45. Grove, J. R., Banerjee, P., Balasubramanyam, A., Coffer, P. J., Price, D. J., Avruch, J. and Woodgett, J. R. (1991) Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini. Mol. Cell. Biol. 11, 5541-5550 (Pubitemid 21895320)
46. Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D. and Krainer, A. R. (2007) The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 14, 185-193 (Pubitemid 46355578)
47. Kim, D., Akcakanat, A., Singh, G., Sharma, C. and Meric-Bernstam, F. (2009) Regulation and localization of ribosomal protein S6 kinase 1 isoforms. Growth Factors 27, 12-21
48. Chou, M. M. and Blenis, J. (1996) The 70kD S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85, 573-583 (Pubitemid 26157195)
49. Romanelli, A., Martin, K. A., Toker, A. and Blenis, J. (1999) p70 S6 kinase is regulated by protein kinase Cζ and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol. Cell. Biol. 19, 2921-2928 (Pubitemid 29144537)
50. Weng, Q. P., Kozlowski, M., Belham, C., Zhang, A., Comb, M. J. and Avruch, J. (1998) Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific antiphosphopeptide antibodies. J. Biol. Chem. 273, 16621-16629 (Pubitemid 28311452)
51. Moser, B. A., Dennis, P. B., Pullen, N., Pearson, R. B., Williamson, N. A., Wettenhall, R. E., Kozma, S. C. and Thomas, G. (1997) Dual requirement for a newly identified phosphorylation site in p70s6k. Mol. Cell. Biol. 17, 5648-5655 (Pubitemid 27357661)
52. Han, J. W., Pearson, R. B., Dennis, P. B. and Thomas, G. (1995) Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70S6k by inducing dephosphorylation of the same subset of sites. J. Biol. Chem. 270, 21396-21403
53. Mukhopadhyay, N. K., Price, D. J., Kyriakis, J. M., Pelech, S., Sanghera, J. and Avruch, J. (1992) An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase. J. Biol. Chem. 267, 3325-3335
54. Ferrari, S., Bannwarth, W., Morley, S. J., Totty, N. F. and Thomas, G. (1992) Activation of p70s6k is associated with phosphorylation of four clustered sites displaying Ser/Thr motifs. Proc. Natl. Acad. Sci. U.S.A. 89, 7282-7286
55. Keshwani, M. M., von Daake, S., Newton, A. C., Harris, T. K. and Taylor, S. S. (2011) Hydrophobic motif phosphorylation is not required for activation loop phosphorylation of p70 ribosomal protein S6 kinase 1 (S6K1). J. Biol. Chem. 286, 23552-23558
56. Oh, W. J., Wu, C. C., Kim, S. J., Facchinetti, V., Julien, L. A., Finlan, M., Roux, P. P., Su, B. and Jacinto, E. (2010) mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J. 29, 3939-3951
57. Price, D. J., Mukhopadhyay, N. K. and Avruch, J. (1991) Insulin-activated protein kinases phosphorylate a pseudosubstrate synthetic peptide inhibitor of the p70 S6 kinase. J. Biol. Chem. 266, 16281-16284 (Pubitemid 21907790)
58. Ferrari, S., Pearson, R. B., Siegmann, M., Kozma, S. C. and Thomas, G. (1993) The immunosuppressant rapamycin induces inactivation of p70S6k through dephosphorylation of a novel set of sites. J. Biol. Chem. 268, 16091-16094 (Pubitemid 23229899)
59. Schalm, S. S. and Blenis, J. (2002) Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12, 632-639 (Pubitemid 34315846)
60. Dennis, P. B., Pullen, N., Pearson, R. B., Kozma, S. C. and Thomas, G. (1998) Phosphorylation sites in the autoinhibitory domain participate in p70(s6k) activation loop phosphorylation. J. Biol. Chem. 273, 14845-14852 (Pubitemid 28272772)
61. Cheatham, L., Monfar, M., Chou, M. M. and Blenis, J. (1995) Structural and functional analysis of p70 S6 kinase. Proc. Natl. Acad. Sci. U.S.A. 92, 11696-11700
62. Weng, Q., Andrabi, K., Kozlowski, M. T., Grove, J. R. and Avruch, J. (1995) Multiple independent inputs are required for activation of the p70 S6 kinase. Mol. Cell. Biol. 15, 2333-2340
63. Dennis, P. B., Pullen, N., Kozma, S. C. and Thomas, G. (1996) The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol. Cell Biol. 16, 6242-6251 (Pubitemid 26360984)
64. Schalm, S. S., Fingar, D. C., Sabatini, D. M. and Blenis, J. (2003) TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 13, 797-806 (Pubitemid 36573247)
65. Nojima, H., Tokunaga, C., Eguchi, S., Oshiro, N., Hidayat, S., Yoshino, K., Hara, K., Tanaka, N., Avruch, J. and Yonezawa, K. (2003) The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J. Biol. Chem. 278, 15461-15464 (Pubitemid 36799651)
66. Schalm, S. S., Tee, A. R. and Blenis, J. (2005) Characterization of a conserved C-terminal motif (RSPRR) in ribosomal protein S6 kinase 1 required for its mammalian target of rapamycin-dependent regulation. J. Biol. Chem. 280, 11101-11106 (Pubitemid 40418414)
67. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B. and Cohen, P. (1997) Characterization of a 3-phosphoinositide- dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7, 261-269 (Pubitemid 27176852)
68. Williams, M. R., Arthur, J. S., Balendran, A., van der Kaay, J., Poli, V., Cohen, P. and Alessi, D. R. (2000) The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10, 439-448 (Pubitemid 30247331)
69. Collins, B. J., Deak, M., Arthur, J. S., Armit, L. J. and Alessi, D. R. (2003) In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. EMBO J. 22, 4202-4211 (Pubitemid 37021748)
70. 3 binding to PDK1 PH domain defined by knockin mutation. EMBO J. 23, 2071-2082
71. Saitoh, M., Pullen, N., Brennan, P., Cantrell, D., Dennis, P. B. and Thomas, G. (2002) Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J. Biol. Chem. 277, 20104-20112 (Pubitemid 34967534)
72. Sunami, T., Byrne, N., Diehl, R. E., Funabashi, K., Hall, D. L., Ikuta, M., Patel, S. B., Shipman, J. M., Smith, R. F., Takahashi, I. et al. (2010) Structural basis of human p70 ribosomal S6 kinase-1 regulation by activation loop phosphorylation. J. Biol. Chem. 285, 4587-4594
73. Frodin, M., Antal, T. L., Dummler, B. A., Jensen, C. J., Deak, M., Gammeltoft, S. and Biondi, R. M. (2002) A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J. 21, 5396-5407 (Pubitemid 35231019)
74. Romanelli, A., Dreisbach, V. C. and Blenis, J. (2002) Characterization of phosphatidylinositol 3-kinase-dependent phosphorylation of the hydrophobic motif site Thr389 in p70 S6 kinase 1. J. Biol. Chem. 277, 40281-40289 (Pubitemid 35215600)
75. Fingar, D. C., Salama, S., Tsou, C., Harlow, E. and Blenis, J. (2002) Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16, 1472-1487 (Pubitemid 34686329)
76. -/-skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat. Cell Biol. 7, 286-294
77. Liu, L., Li, F., Cardelli, J. A., Martin, K. A., Blenis, J. and Huang, S. (2006) Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene 25, 7029-7040 (Pubitemid 44722071)
78. Ali, S. M. and Sabatini, D. M. (2005) Structure of S6 kinase 1 determines whether raptor-mTOR or Rictor-mTOR phosphorylates its hydrophobic motif site. J. Biol. Chem. 280, 19445-19448 (Pubitemid 41379463)
79. Duvel, K. and Broach, J. R. (2004) The role of phosphatases in TOR signaling in yeast. Curr. Top. Microbiol. Immunol. 279, 19-38
80. Westphal, R. S., Coffee, Jr, R. L., Marotta, A., Pelech, S. L. and Wadzinski, B. E. (1999) Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A. J. Biol. Chem. 274, 687-692
81. Peterson, R. T., Desai, B. N., Hardwick, J. S. and Schreiber, S. L. (1999) Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycin associated protein. Proc. Natl. Acad. Sci. U.S.A. 96, 4438-4442 (Pubitemid 29190354)
82. Hahn, K., Miranda, M., Francis, V. A., Vendrell, J., Zorzano, A. and Teleman, A. A. (2010) PP2A regulatory subunit PP2A-B' counteracts S6K phosphorylation. Cell Metab. 11, 438-444
83. Fenton, T. R., Gwalter, J., Ericsson, J. and Gout, I. T. (2010) Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo. Int. J. Biochem. Cell Biol. 42, 359-366
84. Fenton, T. R., Gwalter, J., Cramer, R. and Gout, I. T. (2010) S6K1 is acetylated at lysine 516 in response to growth factor stimulation. Biochem. Biophys. Res. Commun. 398, 400-405
85. Wang, M. L., Panasyuk, G., Gwalter, J., Nemazanyy, I., Fenton, T., Filonenko, V. and Gout, I. (2008) Regulation of ribosomal protein S6 kinases by ubiquitination. Biochem. Biophys. Res. Commun. 369, 382-387
86. Gwalter, J., Wang, M. L. and Gout, I. (2009) The ubiquitination of ribosomal S6 kinases is independent from the mitogen-induced phosphorylation/activation of the kinase. Int. J. Biochem. Cell Biol. 41, 828-833
87. Panasyuk, G., Nemazanyy, I., Filonenko, V. and Gout, I. (2008) Ribosomal protein S6 kinase 1 interacts with and is ubiquitinated by ubiquitin ligase ROC1. Biochem. Biophys. Res. Commun. 369, 339-343
88. Wu, Y. T., Ouyang, W., Lazorchak, A. S., Liu, D., Shen, H. M. and Su, B. (2011) mTOR complex 2 targets Akt for proteasomal degradation via phosphorylation at the hydrophobic motif. J. Biol. Chem. 286, 14190-14198
89. Kim, J. E. and Chen, J. (2000) Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. Proc. Natl. Acad. Sci. U.S.A. 97, 14340-14345 (Pubitemid 32016577)
90. Valovka, T., Verdier, F., Cramer, R., Zhyvoloup, A., Fenton, T., Rebholz, H., Wang, M. L., Gzhegotsky, M., Lutsyk, A., Matsuka, G. et al. (2003) Protein kinase C phosphorylates ribosomal protein S6 kinase βII and regulates its subcellular localization. Mol. Cell. Biol. 23, 852-863 (Pubitemid 36133504)
91. Martin, K. A., Schalm, S. S., Richardson, C., Romanelli, A., Keon, K. L. and Blenis, J. (2001) Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway. J. Biol. Chem. 276, 7884-7891
92. Martin, K. A., Schalm, S. S., Romanelli, A., Keon, K. L. and Blenis, J. (2001) Ribosomal S6 kinase 2 inhibition by a potent C-terminal repressor domain is relieved by mitogen-activated protein extracellular signal-regulated kinase kinase-regulated phosphorylation. J. Biol. Chem. 276, 7892-7898 (Pubitemid 37385584)
93. Phin, S., Kupferwasser, D., Lam, J. and Lee-Fruman, K. K. (2003) Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1. Biochem. J. 373, 583-591 (Pubitemid 36897860)
94. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L. and Sabatini, D. M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159-168
95. Sengupta, S., Peterson, T. R. and Sabatini, D. M. (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 40, 310-322
96. Sarbassov, D. D., Guertin, D. A., Ali, S. M. and Sabatini, D. M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 (Pubitemid 40262113)
97. Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. and Cantley, L. C. (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway. Mol. Cell 10, 151-162 (Pubitemid 34876569)
98. Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A. and Sabatini, D. M. (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25, 903-915 (Pubitemid 46436534)
99. van der Haar, E., Lee, S. I., Bandhakavi, S., Griffin, T. J. and Kim, D. H. (2007) Insulin signaling to mTOR mediated by the AKT/PKB substrate PRAS40. Nat. Cell Biol. 9, 316-323 (Pubitemid 46344611)
100. Huang, J. and Manning, B. D. (2008) The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem. J. 412, 179-190 (Pubitemid 351758225)
101. Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C. and Blenis, J. (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259-1268 (Pubitemid 36953298)
102. Inoki, K., Li, Y., Xu, T. and Guan, K. L. (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829-1834 (Pubitemid 36944560)
103. Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K. and Avruch, J. (2005) Rheb binds and regulates the mTOR kinase. Curr. Biol. 15, 702-713 (Pubitemid 40599924)
104. Sato, T., Nakashima, A., Guo, L. and Tamanoi, F. (2009) Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J. Biol. Chem. 284, 12783-12791
105. Soliman, G. A., Acosta-Jaquez, H. A., Dunlop, E. A., Ekim, B., Maj, N. E., Tee, A. R. and Fingar, D. C. (2010) mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action. J. Biol. Chem. 285, 7866-7879
106. Acosta-Jaquez, H. A., Keller, J. A., Foster, K. G., Ekim, B., Soliman, G. A., Feener, E. P., Ballif, B. A. and Fingar, D. C. (2009) Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth. Mol. Cell. Biol. 29, 4308-4324
107. Ekim, B., Magnuson, B., Acosta-Jaquez, H. A., Keller, J. A., Feener, E. P. and Fingar, D. C. (2011) mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression. Mol. Cell. Biol. 31, 2787-2801
108. Foster, K. G., Acosta-Jaquez, H. A., Romeo, Y., Ekim, B., Soliman, G. A., Carriere, A., Roux, P. P., Ballif, B. A. and Fingar, D. C. (2010) Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. J. Biol. Chem. 285, 80-94
109. Wang, L., Lawrence, Jr, J. C., Sturgill, T. W. and Harris, T. E. (2009) Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR. J. Biol. Chem. 284, 14693-14697
110. Carriere, A., Cargnello, M., Julien, L. A., Gao, H., Bonneil, E., Thibault, P. and Roux, P. P. (2008) Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr. Biol. 18, 1269-1277
111. Carriere, A., Romeo, Y., Acosta-Jaquez, H. A., Moreau, J., Bonneil, E., Thibault, P., Fingar, D. C. and Roux, P. P. (2011) ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). J. Biol. Chem. 286, 567-577
112. Oshiro, N., Takahashi, R., Yoshino, K., Tanimura, K., Nakashima, A., Eguchi, S., Miyamoto, T., Hara, K., Takehana, K., Avruch, J. et al. (2007) The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J. Biol. Chem. 282, 20329-20339 (Pubitemid 47100038)
113. Wang, L., Harris, T. E., Roth, R. A. and Lawrence, Jr, J. C. (2007) PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J. Biol. Chem. 282, 20036-20044 (Pubitemid 47100127)
114. Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S. and Sabatini, D. M. (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873-886
115. Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. and Pandolfi, P. P. (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193 (Pubitemid 40546387)
116. Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P. and Blenis, J. (2004) Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. U.S.A. 101, 13489-13494 (Pubitemid 39238430)
117. Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. and Chen, J. (2001) Phosphatidic acidmediated mitogenic activation of mTOR signaling. Science 294, 1942-1945 (Pubitemid 33101594)
118. Sun, Y., Fang, Y., Yoon, M. S., Zhang, C., Roccio, M., Zwartkruis, F. J., Armstrong, M., Brown, H. A. and Chen, J. (2008) Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc. Natl. Acad. Sci. U.S.A. 105, 8286-8291 (Pubitemid 351904748)
119. Toschi, A., Lee, E., Xu, L., Garcia, A., Gadir, N. and Foster, D. A. (2009) Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol. Cell. Biol. 29, 1411-1420
120. Lee, D. F., Kuo, H. P., Chen, C. T., Hsu, J. M., Chou, C. K., Wei, Y., Sun, H. L., Li, L. Y., Ping, B., Huang, W. C. et al. (2007) IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440-455 (Pubitemid 47198298)
121. Lee, D. F., Kuo, H. P., Chen, C. T., Wei, Y., Chou, C. K., Hung, J. Y., Yen, C. J. and Hung, M. C. (2008) IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance. Int. J. Mol. Med. 22, 633-638
122. Dan, H. C., Adli, M. and Baldwin, A. S. (2007) Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by IκB kinase α. Cancer Res. 67, 6263-6269 (Pubitemid 47037508)
123. Dan, H. C. and Baldwin, A. S. (2008) Differential involvement of IκB kinases α and β in cytokine- and insulin-induced mammalian target of rapamycin activation determined by Akt. J. Immunol. 180, 7582-7589
124. Dan, H. C., Cooper, M. J., Cogswell, P. C., Duncan, J. A., Ting, J. P. and Baldwin, A. S. (2008) Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK. Genes Dev. 22, 1490-1500 (Pubitemid 351793083)
125. Xie, X., Zhang, D., Zhao, B., Lu, M. K., You, M., Condorelli, G., Wang, C. Y. and Guan, K. L. (2011) IκB kinase ε and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 108, 6474-6479
126. Joung, S. M., Park, Z. Y., Rani, S., Takeuchi, O., Akira, S. and Lee, J. Y. (2011) Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1. J. Immunol. 186, 499-507
127. Ou, Y. H., Torres, M., Ram, R., Formstecher, E., Roland, C., Cheng, T., Brekken, R., Wurz, R., Tasker, A., Polverino, T. et al. (2011) TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol. Cell 41, 458-470
128. Smith, E. M., Finn, S. G., Tee, A. R., Browne, G. J. and Proud, C. G. (2005) The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. J. Biol. Chem. 280, 18717-18727 (Pubitemid 41379573)
129. Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C. et al. (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136, 521-534
130. Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L. and Sabatini, D. M. (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501 (Pubitemid 351929429)
131. Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P. and Guan, K. L. (2008) Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10, 935-945
132. Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S. and Sabatini, D. M. (2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290-303
133. Nada, S., Hondo, A., Kasai, A., Koike, M., Saito, K., Uchiyama, Y. and Okada, M. (2009) The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J. 28, 477-489
134. Flinn, R. J., Yan, Y., Goswami, S., Parker, P. J. and Backer, J. M. (2010) The late endosome is essential for mTORC1 signaling. Mol. Biol. Cell 21, 833-841
135. Saci, A., Cantley, L. C. and Carpenter, C. L. (2011) Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Mol. Cell 42, 50-61
136. Shackelford, D. B. and Shaw, R. J. (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer 9, 563-575
137. Inoki, K., Zhu, T. and Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590 (Pubitemid 37506046)
138. Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E. and Shaw, R. J. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226 (Pubitemid 351626684)
139. Zheng, M., Wang, Y. H., Wu, X. N., Wu, S. Q., Lu, B. J., Dong, M. Q., Zhang, H., Sun, P., Lin, S. C., Guan, K. L. and Han, J. (2011) Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1. Nat. Cell Biol. 13, 263-272
140. Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W. and Kaelin, Jr, W. G. (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18, 2893-2904 (Pubitemid 39602308)
141. Sofer, A., Lei, K., Johannessen, C. M. and Ellisen, L. W. (2005) Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol. Cell. Biol. 25, 5834-5845 (Pubitemid 40946541)
142. DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D. and Ellisen, L. W. (2008) Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 22, 239-251
143. Budanov, A. V. and Karin, M. (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134, 451-460
144. Whitney, M. L., Jefferson, L. S. and Kimball, S. R. (2009) ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression. Biochem. Biophys. Res. Commun. 379, 451-455
145. 473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280, 40406-40416
146. Garcia-Martinez, J. M. and Alessi, D. R. (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem. J. 416, 375-385
147. Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J. and Sabatini, D. M. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα, but not S6K1. Dev. Cell 11, 859-871 (Pubitemid 44804279)
148. Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J. and Su, B. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125-137 (Pubitemid 44466632)
149. Sarbassov, D. D., Ali, S. M., Kim, D. H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D. M. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302 (Pubitemid 38991819)
150. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M. A., Hall, A. and Hall, M. N. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128 (Pubitemid 39468014)
151. Facchinetti, V., Ouyang, W., Wei, H., Soto, N., Lazorchak, A., Gould, C., Lowry, C., Newton, A. C., Mao, Y., Miao, R. Q. et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27, 1932-1943
152. Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. and Guan, K. L. (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919-1931
153. Feng, J., Park, J., Cron, P., Hess, D. and Hemmings, B. A. (2004) Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J. Biol. Chem. 279, 41189-41196 (Pubitemid 39287721)
154. Huang, J., Dibble, C. C., Matsuzaki, M. and Manning, B. D. (2008) The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol. Cell. Biol. 28, 4104-4115 (Pubitemid 351812994)
155. Huang, J., Wu, S., Wu, C. L. and Manning, B. D. (2009) Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Res. 69, 6107-6114
156. Jefferies, H. B. J., Reinhard, C., Kozma, S. C. and Thomas, G. (1994) Rapamycin selectively represses translation of the "polypryimidine tract" nRNA family. Proc. Natl. Acad. Sci. U.S.A. 91, 4441-4445
157. Jefferies, H. B., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B. and Thomas, G. (1997) Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J. 16, 3693-3704 (Pubitemid 27250062)
158. Stolovich, M., Tang, H., Hornstein, E., Levy, G., Cohen, R., Bae, S. S., Birnbaum, M. J. and Meyuhas, O. (2002) Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation. Mol. Cell. Biol. 22, 8101-8113 (Pubitemid 35304044)
159. Tang, H., Hornstein, E., Stolovich, M., Levy, G., Livingstone, M., Templeton, D., Avruch, J. and Meyuhas, O. (2001) Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol. Cell. Biol. 21, 8671-8683 (Pubitemid 33108623)
160. Ruvinsky, I., Sharon, N., Lerer, T., Cohen, H., Stolovich-Rain, M., Nir, T., Dor, Y., Zisman, P. and Meyuhas, O. (2005) Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 19, 2199-2211 (Pubitemid 41330321)
161. Patursky-Polischuk, I., Stolovich-Rain, M., Hausner-Hanochi, M., Kasir, J., Cybulski, N., Avruch, J., Ruegg, M. A., Hall, M. N. and Meyuhas, O. (2009) The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner. Mol. Cell. Biol. 29, 640-649
162. Hershey, J. W. (2010) Regulation of protein synthesis and the role of eIF3 in cancer. Braz. J. Med. Biol. Res. 43, 920-930
163. Holz, M. K., Ballif, B. A., Gygi, S. P. and Blenis, J. (2005) mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123, 569-580 (Pubitemid 41608461)
164. Raught, B., Peiretti, F., Gingras, A. C., Livingstone, M., Shahbazian, D., Mayeur, G. L., Polakiewicz, R. D., Sonenberg, N. and Hershey, J. W. (2004) Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J. 23, 1761-1769 (Pubitemid 38649639)
165. Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M. and Sonenberg, N. (2006) The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25, 2781-2791 (Pubitemid 43980385)
166. Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E. and Pagano, M. (2006) S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314, 467-471 (Pubitemid 44628968)
167. Richardson, C. J., Broenstrup, M., Fingar, D. C., Julich, K., Ballif, B. A., Gygi, S. and Blenis, J. (2004) SKAR is a specific target of S6 kinase 1 in cell growth control. Curr. Biol. 14, 1540-1549 (Pubitemid 39290051)
168. Ma, X. M., Yoon, S. O., Richardson, C. J., Julich, K. and Blenis, J. (2008) SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 133, 303-313 (Pubitemid 351508301)
169. Wang, X., Li, W., Williams, M., Terada, N., Alessi, D. R. and Proud, C. G. (2001) Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J. 20, 4370-4379 (Pubitemid 32772031)
170. Abe, Y., Yoon, S. O., Kubota, K., Mendoza, M. C., Gygi, S. P. and Blenis, J. (2009) p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling. J. Biol. Chem. 284, 14939-14948
171. Wilson, K. F., Wu, W. J. and Cerione, R. A. (2000) Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex. J. Biol. Chem. 275, 37307-37310 (Pubitemid 32007059)
172. Montagne, J., Stewart, M. J., Stocker, H., Hafen, E., Kozma, S. C. and Thomas, G. (1999) Drosophila S6 kinase: a regulator of cell size. Science 285, 2126-2129 (Pubitemid 29451430)
173. Deng, H., Hershenson, M. B., Lei, J., Bitar, K. N., Fingar, D. C., Solway, J. and Bentley, J. K. (2010) p70 Ribosomal S6 kinase is required for airway smooth muscle cell size enlargement but not increased contractile protein expression. Am. J. Respir. Cell Mol. Biol. 42, 744-752
174. Pende, M., Kozma, S. C., Jaquet, M., Oorschot, V., Burcelin, R., Le Marchand-Brustel, Y., Klumperman, J., Thorens, B. and Thomas, G. (2000) Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature 408, 994-997
175. Dowling, R. J., Zakikhani, M., Fantus, I. G., Pollak, M. and Sonenberg, N. (2007) Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res. 67, 10804-10812 (Pubitemid 350145909)
176. Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y. L. and Schulze, A. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224-236
177. Fingar, D. C., Richardson, C. J., Tee, A. R., Cheatham, L., Tsou, C. and Blenis, J. (2004) mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 24, 200-216 (Pubitemid 38010048)
178. Cruz, R., Hedden, L., Boyer, D., Kharas, M. G., Fruman, D. A. and Lee-Fruman, K. K. (2005) S6 kinase 2 potentiates interleukin-3-driven cell proliferation. J. Leukocyte Biol. 78, 1378-1385 (Pubitemid 41779244)
179. Goh, E. T., Pardo, O. E., Michael, N., Niewiarowski, A., Totty, N., Volkova, D., Tsaneva, I. R., Seckl, M. J. and Gout, I. (2010) Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway. J. Biol. Chem. 285, 17065-17076
180. Rossi, R., Pester, J. M., McDowell, M., Soza, S., Montecucco, A. and Lee-Fruman, K. K. (2007) Identification of S6K2 as a centrosome-located kinase. FEBS Lett. 581, 4058-4064 (Pubitemid 47212118)
181. Boyer, D., Quintanilla, R. and Lee-Fruman, K. K. (2008) Regulation of catalytic activity of S6 kinase 2 during cell cycle. Mol. Cell. Biochem. 307, 59-64 (Pubitemid 350238647)
182. Shah, O. J., Wang, Z. and Hunter, T. (2004) Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14, 1650-1656 (Pubitemid 39239362)
183. Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R. et al. (2004) The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213-223 (Pubitemid 38988774)
184. Carracedo, A., Ma, L., Teruya-Feldstein, J., Rojo, F., Salmena, L., Alimonti, A., Egia, A., Sasaki, A. T., Thomas, G., Kozma, S. C. et al. (2008) Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J. Clin. Invest. 118, 3065-3074
185. Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J. and Thomas, G. (2004) Absence of S6K1 protects against age and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200-205 (Pubitemid 39243474)
186. Tremblay, F., Brule, S., Hee Um, S., Li, Y., Masuda, K., Roden, M., Sun, X. J., Krebs, M., Polakiewicz, R. D., Thomas, G. and Marette, A. (2007) Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 104, 14056-14061 (Pubitemid 350003334)
187. Ozes, O. N., Akca, H., Mayo, L. D., Gustin, J. A., Maehama, T., Dixon, J. E. and Donner, D. B. (2001) A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. U.S.A. 98, 4640-4645 (Pubitemid 32295029)
188. Holz, M. K. and Blenis, J. (2005) Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J. Biol. Chem. 280, 26089-26093 (Pubitemid 41022201)
189. Chiang, G. G. and Abraham, R. T. (2005) Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem. 280, 25485-25490 (Pubitemid 40962253)
190. Dibble, C. C., Asara, J. M. and Manning, B. D. (2009) Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 29, 5657-5670
191. Julien, L. A., Carriere, A., Moreau, J. and Roux, P. P. (2010) mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol. Cell. Biol. 30, 908-921
192. Treins, C., Warne, P. H., Magnuson, M. A., Pende, M. and Downward, J. (2010) Rictor is a novel target of p70 S6 kinase-1. Oncogene 29, 1003-1016
193. Boulbes, D., Chen, C. H., Shaikenov, T., Agarwal, N. K., Peterson, T. R., Addona, T. A., Keshishian, H., Carr, S. A., Magnuson, M. A., Sabatini, D. M. and Sarbassov, D. D. (2010) Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2. Mol. Cancer Res. 8, 896-906
194. Yu, Y., Yoon, S. O., Poulogiannis, G., Yang, Q., Ma, X. M., Villen, J., Kubica, N., Hoffman, G. R., Cantley, L. C., Gygi, S. P. and Blenis, J. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-1326
195. Hsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B. et al. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322
196. Peng, T., Golub, T. R. and Sabatini, D. M. (2002) The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell. Biol. 22, 5575-5584 (Pubitemid 34755766)
197. Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K. and Puigserver, P. (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex. Nature 450, 736-740 (Pubitemid 350207689)
198. Duvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S. et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell. 39, 171-183
199. Hannan, K. M., Brandenburger, Y., Jenkins, A., Sharkey, K., Cavanaugh, A., Rothblum, L., Moss, T., Poortinga, G., McArthur, G. A., Pearson, R. B. and Hannan, R. D. (2003) mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxyterminal activation domain of the nucleolar transcription factor UBF. Mol. Cell. Biol. 23, 8862-8877 (Pubitemid 37433385)
200. de Groot, R. P., Ballou, L. M. and Sassone-Corsi, P. (1994) Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell 79, 81-91 (Pubitemid 24309515)
201. Yamnik, R. L., Digilova, A., Davis, D. C., Brodt, Z. N., Murphy, C. J. and Holz, M. K. (2009) S6 kinase 1 regulates estrogen receptor α in control of breast cancer cell proliferation. J. Biol. Chem. 284, 6361-6369
202. Zhang, H. H., Lipovsky, A. I., Dibble, C. C., Sahin, M. and Manning, B. D. (2006) S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol. Cell 24, 185-197 (Pubitemid 44574477)
203. Carnevalli, L. S., Masuda, K., Frigerio, F., Le Bacquer, O., Um, S. H., Gandin, V., Topisirovic, I., Sonenberg, N., Thomas, G. and Kozma, S. C. (2010) S6K1 plays a critical role in early adipocyte differentiation. Dev. Cell 18, 763-774
204. Yeh, W. C., Bierer, B. E. and McKnight, S. L. (1995) Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc. Natl. Acad. Sci. U.S.A. 92, 11086-11090
205. Zhang, H. H., Huang, J., Duvel, K., Boback, B., Wu, S., Squillace, R. M., Wu, C. L. and Manning, B. D. (2009) Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS ONE 4, e6189
206. Harada, H., Andersen, J. S., Mann, M., Terada, N. and Korsmeyer, S. J. (2001) p70 S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc. Natl. Acad. Sci. U.S.A. 98, 9666-9670 (Pubitemid 32769360)
207. Lai, K. P., Leong, W. F., Chau, J. F., Jia, D., Zeng, L., Liu, H., He, L., Hao, A., Zhang, H., Meek, D. et al. (2010) S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response. EMBO J. 29, 2994-3006
208. Narayanan, U., Nalavadi, V., Nakamoto, M., Thomas, G., Ceman, S., Bassell, G. J. and Warren, S. T. (2008) S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J. Biol. Chem. 283, 18478-18482
209. Hoeffer, C. A. and Klann, E. (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75
210. Aguilar, V., Alliouachene, S., Sotiropoulos, A., Sobering, A., Athea, Y., Djouadi, F., Miraux, S., Thiaudiere, E., Foretz, M., Viollet, B. et al. (2007) S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab. 5, 476-487 (Pubitemid 46825498)
211. Ruvinsky, I., Katz, M., Dreazen, A., Gielchinsky, Y., Saada, A., Freedman, N., Mishani, E., Zimmerman, G., Kasir, J. and Meyuhas, O. (2009) Mice deficient in ribosomal protein S6 phosphorylation suffer from muscle weakness that reflects a growth defect and energy deficit. PLoS ONE 4, e5618
212. Chakrabarti, P., English, T., Shi, J., Smas, C. M. and Kandror, K. V. (2010) Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes 59, 775-781
213. Soliman, G. A., Acosta-Jaquez, H. A. and Fingar, D. C. (2010) mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes. Lipids 45, 1089-1100
214. Blouet, C., Ono, H. and Schwartz, G. J. (2008) Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. Cell Metab. 8, 459-467
215. Cota, D., Proulx, K., Smith, K. A., Kozma, S. C., Thomas, G., Woods, S. C. and Seeley, R. J. (2006) Hypothalamic mTOR signaling regulates food intake. Science 312, 927-930 (Pubitemid 43727328)
216. Myers, Jr, M. G., Leibel, R. L., Seeley, R. J. and Schwartz, M. W. (2010) Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol. Metab. 21, 643-651
217. Mori, H., Inoki, K., Munzberg, H., Opland, D., Faouzi, M., Villanueva, E. C., Ikenoue, T., Kwiatkowski, D., MacDougald, O. A., Myers, Jr, M. G. and Guan, K. L. (2009) Critical role for hypothalamic mTOR activity in energy balance. Cell Metab. 9, 362-374
218. Choo, A. Y. and Blenis, J. (2009) Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. Cell Cycle 8, 567-572
219. Barlund, M., Monni, O., Kononen, J., Cornelison, R., Torhorst, J., Sauter, G., Kallioniemi, O.-P. and Kallioniemi, A. (2000) Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res. 60, 5340-5344
220. Nardella, C., Lunardi, A., Fedele, G., Clohessy, J. G., Alimonti, A., Kozma, S. C., Thomas, G., Loda, M. and Pandolfi, P. P. (2011) Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis. Cancer Res. 71, 3669-3675
221. Shioi, T., McMullen, J. R., Tarnavski, O., Converso, K., Sherwood, M. C., Manning, W. J. and Izumo, S. (2003) Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107, 1664-1670 (Pubitemid 36397337)
222. Chen, J. K., Chen, J., Neilson, E. G. and Harris, R. C. (2005) Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J. Am. Soc. Nephrol. 16, 1384-1391 (Pubitemid 41716522)
223. Chen, J. K., Chen, J., Thomas, G., Kozma, S. C. and Harris, R. C. (2009) S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am. J. Physiol. Renal Physiol. 297, F585-F593
224. McMullen, J. R., Shioi, T., Zhang, L., Tarnavski, O., Sherwood, M. C., Dorfman, A. L., Longnus, S., Pende, M., Martin, K. A., Blenis, J. et al. (2004) Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor phosphoinositide 3-kinase-induced cardiac hypertrophy. Mol. Cell. Biol. 24, 6231-6240 (Pubitemid 38891125)
225. Antion, M. D., Merhav, M., Hoeffer, C. A., Reis, G., Kozma, S. C., Thomas, G., Schuman, E. M., Rosenblum, K. and Klann, E. (2008) Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity. Learn. Mem. 15, 29-38 (Pubitemid 351171603)
226. Fontana, L., Partridge, L. and Longo, V. D. (2010) Extending healthy life span-from yeast to humans. Science 328, 321-326
227. Yang, Z. and Klionsky, D. J. (2010) Eaten alive: a history of macroautophagy. Nat. Cell Biol. 12, 814-822
228. Madeo, F., Tavernarakis, N. and Kroemer, G. (2010) Can autophagy promote longevity? Nat. Cell Biol. 12, 842-846
229. Yang, Z. and Klionsky, D. J. (2010) Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 22, 124-131
230. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S. et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395
231. Selman, C., Tullet, J. M., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F. et al. (2009) Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326, 140-144
232. Pearce, L. R., Alton, G. R., Richter, D. T., Kath, J. C., Lingardo, L., Chapman, J., Hwang, C. and Alessi, D. R. (2010) Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Biochem. J. 431, 245-255
233. Jung, C. H., Ro, S. H., Cao, J., Otto, N. M. and Kim, D. H. (2010) mTOR regulation of autophagy. FEBS Lett. 584, 1287-1295